Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine

Mayo Clinic Proceedings

Volumn 77, Issue 1, 2002, Pages 12-16

  Samenuk, David ^a   Link, Mark S ^a   Homoud, Munther K ^a   Contreras, Robert ^a   Theohardes, Theoharis C ^a   Wang, Paul J ^a   Estes, N A Mark ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; HERBACEOUS AGENT;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DOSE RESPONSE; DRUG EFFECT; EPHEDRA; FEMALE; HEART INFARCTION; HUMAN; MALE; OUTCOMES RESEARCH; STROKE; SUDDEN DEATH;

EID: 0036141178     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.1.12     Document Type: Article

References (31)

1. Alternative medicine makes inroads, but watch out for curves
2. Real medicine or medicine show? Growth of herbal remedy sales raises issues about value
3. Contamination of botanical dietary supplements by Digitalis lanata
4. Clinical classification of cardiac deaths
5. International diagnostic criteria for acute myocardial infarction and acute stroke
6. Fatal ephedrine intoxication
7. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
8. Cardiovascular toxicity after ingestion of "herbal ecstacy."
9. Hypersensitivity myocarditis associated with ephedra use
10. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink
11. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (ma-huang) as determined by high performance liquid chromatography
12. Content versus label claims in ephedra-containing dietary supplements
13. Autonomic nervous system
14. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists
15. Toxicity of over-the-counter stimulants
16. Stroke associated with ephedrine use
17. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter stimulant
18. Coronary artery spasm after ephedrine in a patient with high spinal anesthesia
19. Ephedrine-induced coronary artery vasospasm in a patient with prior cocaine use
20. Ephedrine abuse causing acute myocardial infarction
21. Ephedrine-induced cardiopathy
22. Ephedrine-induced cardiomyopathy
23. Acute cardiac events temporally related to cocaine abuse
24. Catecholamines and cardiomyopathy: The pathogenesis and potential importance of myofibrillar degeneration
25. Unconventional medicine in the United States: Prevalence, costs, and patterns of use
26. Valvular heart disease associated with fenfluramine-phentermine
27. Sustained-release dexfenfluramine study group. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
28. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
29. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs